Effect of oral contraceptives and doxycycline on endometrial MMP-2 and MMP-9 activity
Kaneshiro, B.; Edelman, A.; Dash, C.; Pandhare, J.; Soli, F.M.; Jensen, J.T.
Contraception 93(1): 65-69
2016
ISSN/ISBN: 1879-0518 PMID: 26408375 DOI: 10.1016/j.contraception.2015.09.006Document Number: 640196
To describe the effect of combined oral contraceptives (COCs) on matrix metalloproteinases MMP-2 and MMP-9 activity and compare MMP activity in women taking a COC with or without doxycycline. Subjects (n=20) underwent endometrial biopsies (1) in the late luteal phase of a baseline cycle prior to initiating COCs, (2) on days 19-21 while taking COCs in a standard 28-day cycle (7-day hormone-free interval) and (3) on days 26-28 while taking active COCs continuously for a 28-day cycle. During the continuous COC cycle, they were randomized to receive daily subantimicrobial dose doxycycline 40mg or placebo. Compared to baseline, COC treatment increased MMP-2 (p<.001) and MMP-9 (p<.001). MMP activity was lower in subjects taking a COC with doxycycline compared to those receiving placebo although only significantly lower for MMP-2 latent form (p=.002). Unscheduled bleeding with COCs may be the result of increased endometrial MMPs. Sample size limitations prevent us from determining how doxycycline affects MMP activity in COC users.
Document emailed within 0-6 h
